292 related articles for article (PubMed ID: 15217514)
21. Cytochrome P4501A1 genetic polymorphisms and breast cancer risk in Nigerian women.
Okobia M; Bunker C; Zmuda J; Kammerer C; Vogel V; Uche E; Anyanwu S; Ezeome E; Ferrell R; Kuller L
Breast Cancer Res Treat; 2005 Dec; 94(3):285-93. PubMed ID: 16254684
[TBL] [Abstract][Full Text] [Related]
22. Studies on CYP1A1, CYP1B1 and CYP3A4 gene polymorphisms in breast cancer patients.
Ociepa-Zawal M; Rubiś B; Filas V; Breborowicz J; Trzeciak WH
Ginekol Pol; 2009 Nov; 80(11):819-23. PubMed ID: 20088394
[TBL] [Abstract][Full Text] [Related]
23. CYP1A1 and CYP1B1 genetic polymorphisms, smoking and breast cancer risk in a Finnish Caucasian population.
Sillanpää P; Heikinheimo L; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Metsola K; Hirvonen A
Breast Cancer Res Treat; 2007 Sep; 104(3):287-97. PubMed ID: 17063266
[TBL] [Abstract][Full Text] [Related]
24. Meta-analysis of the association of CYP1A1 polymorphisms with gastric cancer susceptibility and interaction with tobacco smoking.
Han F; Wang X; Wang X; Luo Y; Li W
Mol Biol Rep; 2012 Aug; 39(8):8335-44. PubMed ID: 22707145
[TBL] [Abstract][Full Text] [Related]
25. CYP1A1 gene polymorphisms: lack of association with breast cancer susceptibility in the southern region (Madurai) of India.
Kiruthiga PV; Kannan MR; Saraswathi C; Pandian SK; Devi KP
Asian Pac J Cancer Prev; 2011; 12(8):2133-8. PubMed ID: 22292665
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms in the DNA repair gene XRCC1 and breast cancer.
Duell EJ; Millikan RC; Pittman GS; Winkel S; Lunn RM; Tse CK; Eaton A; Mohrenweiser HW; Newman B; Bell DA
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):217-22. PubMed ID: 11303590
[TBL] [Abstract][Full Text] [Related]
27. GSTM1 and GSTT1 polymorphisms, cigarette smoking, and risk of colon cancer: a population-based case-control study in North Carolina (United States).
Huang K; Sandler RS; Millikan RC; Schroeder JC; North KE; Hu J
Cancer Causes Control; 2006 May; 17(4):385-94. PubMed ID: 16596290
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women.
Trabert B; Malone KE; Daling JR; Doody DR; Bernstein L; Ursin G; Marchbanks PA; Strom BL; Humphrey MC; Ostrander EA
Breast Cancer Res; 2007; 9(6):R84. PubMed ID: 18067661
[TBL] [Abstract][Full Text] [Related]
29. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
[TBL] [Abstract][Full Text] [Related]
30. [Allelic variants of cytochrome P4501A1 (CYP1A1), glutathione S transferase M1 (GSTM1) polymorphisms and their association with smoking and alcohol consumption as gastric cancer susceptibility biomarkers].
Lee K; Cáceres D; Varela N; Csendes D A; Ríos R H; Quiñones S L
Rev Med Chil; 2006 Sep; 134(9):1107-15. PubMed ID: 17171211
[TBL] [Abstract][Full Text] [Related]
31. Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk.
Moysich KB; Shields PG; Freudenheim JL; Schisterman EF; Vena JE; Kostyniak P; Greizerstein H; Marshall JR; Graham S; Ambrosone CB
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):41-4. PubMed ID: 9950238
[TBL] [Abstract][Full Text] [Related]
32. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.
Shah PP; Singh AP; Singh M; Mathur N; Pant MC; Mishra BN; Parmar D
Mutat Res; 2008 Mar; 639(1-2):1-10. PubMed ID: 18082227
[TBL] [Abstract][Full Text] [Related]
33. CYP1A1*2 and CYP1A1*3 polymorphisms cosegregate in the Indian population.
Kotekar A; Bhisey R
Anthropol Anz; 2002 Sep; 60(3):255-60. PubMed ID: 12378791
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in CYP1A1 and ethnic-specific susceptibility to acute lymphoblastic leukemia in children.
Swinney RM; Beuten J; Collier AB; Chen TT; Winick NJ; Pollock BH; Tomlinson GE
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1537-42. PubMed ID: 21586621
[TBL] [Abstract][Full Text] [Related]
35. Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility.
Xu X; Kelsey KT; Wiencke JK; Wain JC; Christiani DC
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):687-92. PubMed ID: 8877059
[TBL] [Abstract][Full Text] [Related]
36. The Effect of the CYP1A1*2A Allele on Colorectal Cancer Susceptibility in a British Population.
Öztaş E; Özhan G; Daly AK
Genet Test Mol Biomarkers; 2016 Aug; 20(8):475-7. PubMed ID: 27243113
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in the carcinogen detoxification genes CYB5A and CYB5R3 and breast cancer risk in African American women.
Blanke KL; Sacco JC; Millikan RC; Olshan AF; Luo J; Trepanier LA
Cancer Causes Control; 2014 Nov; 25(11):1513-21. PubMed ID: 25225034
[TBL] [Abstract][Full Text] [Related]
38. Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer risk.
Taioli E; Bradlow HL; Garbers SV; Sepkovic DW; Osborne MP; Trachman J; Ganguly S; Garte SJ
Cancer Detect Prev; 1999; 23(3):232-7. PubMed ID: 10337002
[TBL] [Abstract][Full Text] [Related]
39. No association between the MDM2 -309 T/G promoter polymorphism and breast cancer in African-Americans or Whites.
Millikan RC; Heard K; Winkel S; Hill EJ; Heard K; Massa B; Mayes L; Williams P; Holston R; Conway K; Edmiston S; de Cotret AR
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):175-7. PubMed ID: 16434608
[No Abstract] [Full Text] [Related]
40. A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women.
Taioli E; Trachman J; Chen X; Toniolo P; Garte SJ
Cancer Res; 1995 Sep; 55(17):3757-8. PubMed ID: 7641189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
